{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T12:00:21Z","timestamp":1769860821575,"version":"3.49.0"},"reference-count":25,"publisher":"Bentham Science Publishers Ltd.","issue":"1","funder":[{"DOI":"10.13039\/501100001411","name":"ICMR, Indian Council of Medical Research, New Delhi, India","doi-asserted-by":"publisher","award":["2019-3458"],"award-info":[{"award-number":["2019-3458"]}],"id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001411","name":"ICMR, Indian Council of Medical Research, New Delhi, India","doi-asserted-by":"publisher","award":["ISRM\/11(54)\/2019"],"award-info":[{"award-number":["ISRM\/11(54)\/2019"]}],"id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CDDT"],"published-print":{"date-parts":[[2023,1]]},"abstract":"<jats:sec>\n<jats:title>Background:<\/jats:title>\n<jats:p>Flavanone compounds and its related derivatives are reported to participating in controlling cell cycle, Angiogenesis, and metastasis. Phosphoinositide 3-kinases is major drug target.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Methods:<\/jats:title>\n<jats:p>Crystalize structure of Phosphoinositide 3-kinases-Akt complex obtained from Protein Data Bank (PDBID: 3CQW) was selected as receptor protein and binding site has been identified with PDBSum Database. Flavanone and its derivatives were retrieved using freely available existing drug database like Drug Bank, Zinc and PubChem. Modifications of new derivatives was performed by altering the flavanone at Beta ring position this modification would help in maintaining stable structural conformation and retaining better anticancer activity. Retrieved Flavanone derivatives from the drug database were docked against 3CQW Protein with advance docking tool FlexX. MD simulations of best molecule were performed with Desmond package by calculating nonbonding interactions such as electrostatic interaction and hydrogen bond stable and favorable conformations were calculated.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Results:<\/jats:title>\n<jats:p>These interaction studies would help in identifying new potential drug candidate with the help of computer aided drug designing techniques.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusion:<\/jats:title>\n<jats:p>Natural chemicals have received a lot of attention because of their vast range of applications in human health and disease prevention without creating any negative side effects. Molecular docking is an essential approach for drug development since it allows for effective screening of potential therapeutics in a short amount of time. We hypothesized in this paper that natural Flavanone and its derivatives may be effective as Akt-1 inhibitors.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1570163819666220526150152","type":"journal-article","created":{"date-parts":[[2022,6,3]],"date-time":"2022-06-03T11:56:07Z","timestamp":1654257367000},"update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Molecular Docking and Simulation Studies of Flavanone and its Derived\nCompounds on PI3K-AKT Pathway Targeting against Cancer"],"prefix":"10.2174","volume":"20","author":[{"given":"K. Venkateswara","family":"Swamy","sequence":"first","affiliation":[{"name":"MIT School of Bioengineering\nSciences &amp; Research, MIT Art, Design and Technology University, Pune 412201, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7911-8690","authenticated-orcid":true,"given":"Sagar","family":"Nagare","sequence":"additional","affiliation":[{"name":"School of Biotechnology and Bioinformatics, D.Y. Patil Deemed to be University, CBD Belapur, Navi Mumbai,\nMaharashtra, 400614, India"},{"name":"Bioinformatics Research Laboratory, Dr. D.Y. Patil Biotechnology and Bioinformatics\nInstitute, Dr. D.Y. Patil Vidyapeeth, Tathawade, Pune, Maharashtra, 411033, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kiran Bharat","family":"Lokhande","sequence":"additional","affiliation":[{"name":"Bioinformatics Research Laboratory, Dr. D.Y. Patil Biotechnology and Bioinformatics\nInstitute, Dr. D.Y. Patil Vidyapeeth, Tathawade, Pune, Maharashtra, 411033, India"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1038\/nrg1879","volume":"7","author":"Engelman J.A.","year":"2006","unstructured":"Engelman J.A.; Luo J.; Cantley L.C.; The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism. Nat Rev Genet 2006,7(8),606-619","journal-title":"Nat Rev Genet"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1038\/nrc1753","volume":"5","author":"Bader A.G.","year":"2005","unstructured":"Bader A.G.; Kang S.; Zhao L.; Vogt P.K.; Oncogenic PI3K deregulates transcription and translation. Nat Rev Cancer 2005,5(12),921-929","journal-title":"Nat Rev Cancer"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1038\/nrc839","volume":"2","author":"Vivanco I.","year":"2002","unstructured":"Vivanco I.; Sawyers C.L.; The phosphatidylinositol 3-Kinase AKT pathway in human cancer. Nat Rev Cancer 2002,2(7),489-501","journal-title":"Nat Rev Cancer"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"4240","DOI":"10.1073\/pnas.96.8.4240","volume":"96","author":"Cantley L.C.","year":"1999","unstructured":"Cantley L.C.; Neel B.G.; New insights into tumor suppression: PTEN suppresses tumor formation by restraining the phos-phoinositide 3-kinase\/AKT pathway. Proc Natl Acad Sci USA 1999,96(8),4240-4245","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1038\/nrc1819","volume":"6","author":"Cully M.","year":"2006","unstructured":"Cully M.; You H.; Levine A.J.; Mak T.W.; Beyond PTEN mutations: The PI3K pathway as an integrator of multiple inputs during tumorigenesis. Nat Rev Cancer 2006,6(3),184-192","journal-title":"Nat Rev Cancer"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1038\/nrd1902","volume":"4","author":"Hennessy B.T.","year":"2005","unstructured":"Hennessy B.T.; Smith D.L.; Ram P.T.; Lu Y.; Mills G.B.; Exploit-ing the PI3K\/AKT pathway for cancer drug discovery. Nat Rev Drug Discov 2005,4(12),988-1004","journal-title":"Nat Rev Drug Discov"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1146\/annurev.biochem.67.1.481","volume":"67","author":"Fruman D.A.","year":"1998","unstructured":"Fruman D.A.; Meyers R.E.; Cantley L.C.; Phosphoinositide kinases. Annu Rev Biochem 1998,67(1),481-507","journal-title":"Annu Rev Biochem"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"9977","DOI":"10.1074\/jbc.M512502200","volume":"281","author":"Voigt P.","year":"2006","unstructured":"Voigt P.; Dorner M.B.; Schaefer M.; Characterization of p87PIKAP, a novel regulatory subunit of phosphoinositide 3-kinase gamma that is highly expressed in heart and interacts with PDE3B. J Biol Chem 2006,281(15),9977-9986","journal-title":"J Biol Chem"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1016\/j.cub.2005.02.020","volume":"15","author":"Suire S.","year":"2005","unstructured":"Suire S.; Coadwell J.; Ferguson G.J.; Davidson K.; Hawkins P.; Stephens L.; p84, a new Gbetagamma-activated regulatory subunit of the type IB phosphoinositide 3-kinase. Curr Biol 2005,15(6),566-570","journal-title":"Curr Biol"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"8077","DOI":"10.1073\/pnas.0702663104","volume":"104","author":"Chang J.D.","year":"2007","unstructured":"Chang J.D.; Sukhova G.K.; Libby P.; Deletion of the phos-phoinositide 3-kinase p110gamma gene attenuates murine atherosclerosis. Proc Natl Acad Sci USA 2007,104(19),8077-8082","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/j.cell.2004.07.017","volume":"118","author":"Patrucco E.","year":"2004","unstructured":"Patrucco E.; Notte A.; Barberis L.; PI3Kgamma modu-lates the cardiac response to chronic pressure overload by distinct kinasedependent and independent effects. Cell 2004,118(3),375-387","journal-title":"Cell"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/S0898-6568(01)00271-6","volume":"14","author":"Nicholson K.M.","year":"2002","unstructured":"Nicholson K.M.; Anderson N.G.; The protein kinase B\/Akt signalling pathway in human malignancy. Cell Signal 2002,14(5),381-395","journal-title":"Cell Signal"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/s12935-017-0404-z","volume":"17","author":"Lowe H.I.C.","year":"2017","unstructured":"Lowe H.I.C.; Toyang N.J.; Watson C.T.; Ayeah K.N.; Bryant J.; HLBT-100: A highly potent anti-cancer flavanone from Tillandsia recurvata (L.) L. Cancer Cell Int 2017,17(1),38","journal-title":"Cancer Cell Int"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1146\/annurev.cellbio.17.1.615","volume":"17","author":"Katso R.","year":"2001","unstructured":"Katso R.; Okkenhaug K.; Ahmadi K.; White S.; Timms J.; Water-field M.D.; Cellular function of phosphoinositide 3-kinases: Implications for development, homeostasis, and cancer. Annu Rev Cell Dev Biol 2001,17(1),615-675","journal-title":"Annu Rev Cell Dev Biol"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1006\/jmbi.1996.0477","volume":"261","author":"Rarey M.","year":"1996","unstructured":"Rarey M.; Kramer B.; Lengauer T.; Klebe G.; A fast flexible docking method using an incremental construction algorithm. J Mol Biol 1996,261(3),470-489","journal-title":"J Mol Biol"},{"key":"ref=16","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0025681","volume":"6","author":"Fowler Z.L.","year":"2011","unstructured":"Fowler Z.L.; Shah K.; Panepinto J.C.; Jacobs A.; Koffas M.A.; Development of non-natural flavanones as antimicrobial agents. PLoS One 2011,6(10)","journal-title":"PLoS One"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1080\/10426500701313896","volume":"182","author":"Ali T.E-S.","year":"2007","unstructured":"Ali T.E-S.; Synthesis and fungicidal activity of some new 4h-chromen-4-ones containing some 1,3-thiazole, 1,3-thiazine, 1,2,4-triazole and 1,2,4-triazine moieties. Phosphorus Sulfur Silicon Relat Elem 2007,182(8),1717","journal-title":"Phosphorus Sulfur Silicon Relat Elem"},{"key":"ref=18","first-page":"163","volume":"76","author":"Murti Y.","year":"2014","unstructured":"Murti Y.; Mishra P.; Synthesis and evaluation of flavanones as anticancer agents. Indian J Pharm Sci 2014,76(2),163-166","journal-title":"Indian J Pharm Sci"},{"key":"ref=19","doi-asserted-by":"publisher","DOI":"10.4314\/ajcem.v9i3.7499","volume":"9","author":"Joseph L.","year":"2008","unstructured":"Joseph L.; George M.; Kassaye G.; One pot method for the synthesis of arylidene flavanones and some of its activities. Afr J Clin Exp Microbiol 2008,9(3)","journal-title":"Afr J Clin Exp Microbiol"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"3359","DOI":"10.1016\/j.bmcl.2008.04.034","volume":"18","author":"Lippa B.","year":"2008","unstructured":"Lippa B.; Pan G.; Corbett M.; Synthesis and structure based optimization of novel Akt inhibitors. Bioorg Med Chem Lett 2008,18(11),3359-3363","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=21","doi-asserted-by":"publisher","DOI":"10.1109\/SC.2006.54","author":"Bowers K.J.","unstructured":"Bowers K.J.; Chow E.; Xu H.; Scalable algorithms for molecular dynamics simulations on commodity clusters. Proceedings of the ACM\/IEEE Conference on Supercompu-ting (SC06)","journal-title":"Proceedings of the ACM\/IEEE Conference on Supercompu-ting (SC06)"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"2699","DOI":"10.1093\/nar\/gky092","volume":"46","year":"2018","unstructured":"UniProt Consortium T. UniProt: The universal protein knowledgebase. Nucleic Acids Res 2018,46(5),2699","journal-title":"Nucleic Acids Res"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1002\/pro.3289","volume":"27","author":"Laskowski RA","year":"2018","unstructured":"Laskowski RA; Jab\u0142o\u0144ska J, Pravda L, Va\u0159ekov&#xE1; R S, Thornton J M. PDBsum: Structural summaries of PDB en-tries. Protein Sci 2018,27(1),129-134","journal-title":"Protein Sci"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/07391102.2020.1858165","author":"Lokhande K.","year":"2020","unstructured":"Lokhande K.; Nawani N.; K Venkateswara S, Pawar S. Bifla-vonoids from Rhus succedanea as probable natural inhibi-tors against SARS-CoV-2: A molecular docking and molecu-lar dynamics approach. J Biomol Struct Dyn 2020,1-13","journal-title":"J Biomol Struct Dyn"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"7294","DOI":"10.1080\/07391102.2020.1805019","volume":"39","author":"Lokhande K.B.","year":"2021","unstructured":"Lokhande K.B.; Doiphode S.; Vyas R.; Swamy K.V.; Molecular docking and simulation studies on SARS-CoV-2 Mpro reveals Mitoxantrone, Leucovorin, Birinapant, and Dynasore as potent drugs against COVID-19. J Biomol Struct Dyn 2021,39(18),7294-7305","journal-title":"J Biomol Struct Dyn"}],"container-title":["Current Drug Discovery Technologies"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1570163819666220526150152","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/205302\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1570163819666220526150152","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,16]],"date-time":"2023-03-16T12:48:59Z","timestamp":1678970939000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/205302\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,1]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1570163819666220526150152","relation":{},"ISSN":["1570-1638"],"issn-type":[{"value":"1570-1638","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2021-08-28","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-12-21","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-02-28","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-01-19","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e260522205302"}}